ESSA Pharma Inc.
Develops novel small molecule drugs to treat castration-resistant prostate cancer.
EPIX | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- SUITE 720, 0 VANCOUVER
- Website:
- https://www.essapharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
ESSA Pharma Inc. is a clinical-stage pharmaceutical company focused on the research, development, and commercialization of novel therapies for the treatment of prostate cancer. The company specializes in developing proprietary small molecule drugs, with a particular focus on castration-resistant prostate cancer (CRPC). In late 2025, ESSA Pharma announced it had entered into a definitive agreement to be acquired by XenoTherapeutics, Inc.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ESSA Pharma Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ESSA Pharma Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ESSA Pharma Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
